Fresenius SE & Co KGaA

Common Name

Fresenius SE & Co

Country

Germany

Sector

Healthcare

Industry

Medical Care Facilities

Employees

176,207

Ticker

FRE

Exchange

XETRA

Website

www.fresenius.com

Description

Fresenius SE & Co. KGaA is a globally operating healthcare group involved in providing products and services for dialysis, hospitals, and medical care facilities. As a key player in the healthcare ind... Show more

Financial Statements of Fresenius SE & Co

Below are the financial statements of Fresenius SE & Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of EUR	2024	2023
Assets	—	—
Cash and cash equivalents	2.28^a	2.56^a
Trade accounts and other receivables, less allowances for expected credit losses	3.5^a	3.67^a
Inventories	2.57^a	2.52^a
Other financial assets	1.42^a	1.5^a
Other assets	1.15^a	1.53^a
Income tax receivables	0.21^a	0.18^a
Assets held for sale	0.31^a	0.56^a
Total current assets	11.45^a	12.52^a
Property, plant and equipment	8.57^a	8.96^a
Right-of-use assets	1.32^a	1.82^a
Goodwill	15.09^a	15.09^a
Other intangible assets	2.42^a	2.53^a
Fresenius Medical Care investment accounted for using the equity method	3.64^a	3.5^a
Other financial assets	0.43^a	0.36^a
Other assets	0.23^a	0.14^a
Deferred taxes	0.41^a	0.36^a
Total non-current assets	32.1^a	32.76^a
Total assets	43.55^a	45.28^a
Liabilities and shareholders’ equity	—	—
Trade accounts payable	1.36^a	1.49^a
Debt	0.75^a	1.06^a
Lease liabilities	0.17^a	0.21^a
Bonds	1.85^a	0.82^a
Convertible bonds	0^a	0.5^a
Other financial liabilities	1.55^a	1.64^a
Other liabilities	2.09^a	2.48^a
Provisions	0.66^a	0.8^a
Income tax liabilities	0.15^a	0.11^a
Liabilities directly associated with the assets held for sale	0.42^a	0.23^a
Total short-term liabilities	9.01^a	9.33^a
Debt	1.74^a	2.22^a
Lease liabilities	1.33^a	1.79^a
Bonds	7.74^a	9.24^a
Other financial liabilities	0.97^a	0.83^a
Other liabilities	0.25^a	0.23^a
Pension liabilities	0.61^a	0.67^a
Provisions	0.72^a	0.52^a
Income tax liabilities	0.28^a	0.28^a
Deferred taxes	0.63^a	0.53^a
Total long-term liabilities	14.25^a	16.3^a
Total liabilities	23.26^a	25.63^a
Noncontrolling interests	0.75^a	0.65^a
Subscribed capital	0.56^a	0.56^a
Capital reserve	4.32^a	4.33^a
Other reserves	14.04^a	14.09^a
Accumulated other comprehensive income	0.63^a	0.02^a
Total Fresenius SE & Co. KGaA shareholders’ equity	19.54^a	19^a
Total shareholders’ equity	20.29^a	19.65^a
Total liabilities and shareholders’ equity	43.55^a	45.28^a

Verified Sources Behind Fresenius SE & Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fresenius SE & Co’s data sources below and access millions more through our Disclosure Search.

a. Fresenius SE & Co's Annual Report 2024

Trace every data point back to Fresenius SE & Co’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Fresenius SE & Co KGaA

Financial Statements of Fresenius SE & Co

Verified Sources Behind Fresenius SE & Co’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Fresenius Medical Care AG

Siemens Healthineers AG

Merck KGaA

Bayer AG

Sartorius AG

SCHOTT Pharma AG & Co KgaA